Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Pitfalls due to improper positioning of Impella®CP device for left ventricular support: a case series

View through CrossRef
Background: The Impella® device is a type of antegrade left ventricular assist device that includes a pump catheter designed to reside in the mid-left ventricular cavity. It has received approval for temporary use in providing left ventricular support, with the aim of augmenting cardiac output and reducing myocardial oxygen demand. We document four cases in which we encountered challenges in circulatory management during Impella device insertion. These challenges arose from issues such as incorrect positioning leading to restricted maximum flow rate or the development of new-onset aortic insufficiency (AI) associated with the placement of the device. Cases presentation: Two of our four patients showed improper positioning; either the inlet part was too much in the ventricle or too close to the heart wall. Due to the placement of the Impella, all four patients experienced the development of new-onset aortic insufficiency with a relatively low total assisted flow rate. In one of the cases, sufficient total flow was achieved when the Impella device was utilized alongside veno-arterial extracorporeal membrane oxygenation (ECMO). Conclusion: Circulatory management with Impella device insertion can be challenging due to certain pitfalls, such as the incorrect positioning of Impella and the development of AI following Impella placement with a restricted flow rate. During the acute phase when patients experience deteriorating cardiogenic shock, the use of ECMO for management is considered to be an effective approach. Abbreviations: ECMO: Extra-corporeal membranous oxygenation; PCPS: Percutaneous cardiopulmonary support; LVAD: Left ventricular assist device; LVEF: Left ventricular ejection fraction; CCO: Continuous cardiac output; AI: Aortic insufficiency. Keywords:  Aortic Insufficiency; ECMO; Cardiogenic Shock; Impella; Ventricular Assist Device Citation: Abdalwahab A, Ismail AA, Hammad YM. Pitfalls due to improper positioning of Impella®CP device for left ventricular support: a case series. Anaesth. pain intensive care 2024;28(5):119-123. DOI: 10.35975/apic.v29i1.2656 Received: November 24, 2024; Reviewed: December 30, 2024; Accepted: December 30, 2024
Title: Pitfalls due to improper positioning of Impella®CP device for left ventricular support: a case series
Description:
Background: The Impella® device is a type of antegrade left ventricular assist device that includes a pump catheter designed to reside in the mid-left ventricular cavity.
It has received approval for temporary use in providing left ventricular support, with the aim of augmenting cardiac output and reducing myocardial oxygen demand.
We document four cases in which we encountered challenges in circulatory management during Impella device insertion.
These challenges arose from issues such as incorrect positioning leading to restricted maximum flow rate or the development of new-onset aortic insufficiency (AI) associated with the placement of the device.
Cases presentation: Two of our four patients showed improper positioning; either the inlet part was too much in the ventricle or too close to the heart wall.
Due to the placement of the Impella, all four patients experienced the development of new-onset aortic insufficiency with a relatively low total assisted flow rate.
In one of the cases, sufficient total flow was achieved when the Impella device was utilized alongside veno-arterial extracorporeal membrane oxygenation (ECMO).
Conclusion: Circulatory management with Impella device insertion can be challenging due to certain pitfalls, such as the incorrect positioning of Impella and the development of AI following Impella placement with a restricted flow rate.
During the acute phase when patients experience deteriorating cardiogenic shock, the use of ECMO for management is considered to be an effective approach.
Abbreviations: ECMO: Extra-corporeal membranous oxygenation; PCPS: Percutaneous cardiopulmonary support; LVAD: Left ventricular assist device; LVEF: Left ventricular ejection fraction; CCO: Continuous cardiac output; AI: Aortic insufficiency.
Keywords:  Aortic Insufficiency; ECMO; Cardiogenic Shock; Impella; Ventricular Assist Device Citation: Abdalwahab A, Ismail AA, Hammad YM.
Pitfalls due to improper positioning of Impella®CP device for left ventricular support: a case series.
Anaesth.
pain intensive care 2024;28(5):119-123.
DOI: 10.
35975/apic.
v29i1.
2656 Received: November 24, 2024; Reviewed: December 30, 2024; Accepted: December 30, 2024.

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Hydatid Cyst of The Orbit: A Systematic Review with Meta-Data
Abstarct Introduction Orbital hydatid cysts (HCs) constitute less than 1% of all cases of hydatidosis, yet their occurrence is often linked to severe visual complications. This stu...
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
Cardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion. The ...
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
IABP Versus Impella Support in Cardiogenic Shock: “In Silico” Study
Cardiogenic shock (CS) is part of a clinical syndrome consisting of acute left ventricular failure causing severe hypotension leading to inadequate organ and tissue perfusion. The ...
Increasing use of the Impella®-pump in severe cardiogenic shock: a word of caution
Increasing use of the Impella®-pump in severe cardiogenic shock: a word of caution
Abstract Impella® pumps are increasingly utilized in patients in cardiogenic shock. We report on a case series where Impella support was insufficient, and a switch t...
Renal Protection and Hemodynamic Improvement by Impella® Microaxial Pump in Patients with Cardiogenic Shock
Renal Protection and Hemodynamic Improvement by Impella® Microaxial Pump in Patients with Cardiogenic Shock
Acute kidney injury is one of the most frequent and prognostically relevant complications in cardiogenic shock. The purpose of this study was to evaluate the potential effect of th...
Breast Carcinoma within Fibroadenoma: A Systematic Review
Breast Carcinoma within Fibroadenoma: A Systematic Review
Abstract Introduction Fibroadenoma is the most common benign breast lesion; however, it carries a potential risk of malignant transformation. This systematic review provides an ove...
Less Invasive Left Ventricular Unloading With Impella May Improve the Clinical Outcomes of Fulminant Myocarditis
Less Invasive Left Ventricular Unloading With Impella May Improve the Clinical Outcomes of Fulminant Myocarditis
Fulminant myocarditis (FM) requiring temporary mechanical circulatory support (t-MCS) has a high mortality rate. Peripheral veno-arterial extracorporeal membrane oxygenation (VA-EC...

Back to Top